Skip to main content
New: Manufacturing Quotes — source from manufacturers in 35 countries.Start a Project
GH
Sample brief

Digital Therapeutic for Type 2 Diabetes: Germany vs UAE vs Saudi Arabia

A demo GHMAP market-access output showing how source status, review needs, evidence gaps, and next actions can be organized before launch prioritization.

Demo brief for product illustration only. Source verification and professional review required before business use.

Brief metadata

Market-access brief control panel

Product category
Digital therapeutic
Indication/use case
Type 2 diabetes support program
Countries
Germany, UAE, Saudi Arabia
Project objective
Compare market-access questions before launch prioritization
Source status
Source required / To verify
Confidence status
Demo only / Professional review required
Review owner
Market-access reviewer
Export status
Locked until source review
Country comparison dashboard

Country questions stay separated from conclusions.

This demo shows the type of country-by-country question structure GHMAP can organize. It does not provide actual regulatory, reimbursement, payer, procurement, or pricing conclusions.

CountryRegulatory questionReimbursement questionPayer/procurement questionEvidence gapRequired source typeStatusNext action
GermanyConfirm applicable pathway with official source.Identify payer or reimbursement route requiring verification.Map public/private payer or procurement process.Local evidence expectations to verify.Official regulator / payer / HTA / procurement source required.To verifyAttach source and assign reviewer.
UAEConfirm applicable pathway with official source.Identify payer or reimbursement route requiring verification.Map public/private payer or procurement process.Local evidence expectations to verify.Official regulator / payer / HTA / procurement source required.To verifyAttach source and assign reviewer.
Saudi ArabiaConfirm applicable pathway with official source.Identify payer or reimbursement route requiring verification.Map public/private payer or procurement process.Local evidence expectations to verify.Official regulator / payer / HTA / procurement source required.To verifyAttach source and assign reviewer.
Evidence readiness matrix

Evidence gaps become reviewable work items.

The matrix keeps each evidence category tied to a country, source requirement, owner role, and current status.

Evidence areaGermanyUAESaudi ArabiaRequired sourceOwner roleStatus
Product classificationSource requiredTo verifySource requiredOfficial regulator sourceRegulatory reviewerIncomplete
Clinical evidenceTo verifySource requiredTo verifyApproved evidence packageClinical evidence reviewerProfessional review required
Economic evidenceSource requiredTo verifySource requiredEconomic evidence sourceHealth economics reviewerIncomplete
Local payer expectationsTo verifyTo verifySource requiredPayer / reimbursement sourceReimbursement reviewerSource required
Procurement/tender evidenceDemo onlySource requiredTo verifyProcurement / tender sourceProcurement reviewerSource required
Competitor contextExample onlyExample onlyExample onlyVerified market context sourceMarket-access analystDemo only
Local expert reviewProfessional review requiredProfessional review requiredProfessional review requiredReviewer noteLocal expert reviewerProfessional review required
Review workflow timeline

A brief stays locked until source and professional review work is complete.

Most stages in this public demo remain marked demo, incomplete, or locked so the output does not imply reliance-ready content.

  1. 1

    Draft created

    Demo only
  2. 2

    Source requirements identified

    Example only
  3. 3

    Evidence attached

    Incomplete
  4. 4

    AI brief generated

    Demo preview
  5. 5

    Reviewer assigned

    To verify
  6. 6

    Professional review completed

    Not completed
  7. 7

    Export approved

    Locked
AI brief output format

Source-aware AI preview

Summary

GHMAP would summarize attached, approved sources here.

Assumptions

Assumptions remain unverified until sources are attached.

Missing evidence

Official sources required before business reliance.

Source list

No verified source attached in this demo.

Confidence

Demo only / insufficient for reliance.

Human review required

Professional review required.

Recommended next actions

Attach sources, assign reviewer, confirm country-specific pathway.

Export preview

Export available after source review.

Export actions are disabled in this public demo. The brief remains locked until source review and professional review are complete.

Source status, evidence gaps, review needs, and next actions stay visible before export.

Sample brief workflow

See how GHMAP structures a market-access brief before launch decisions.

Use GHMAP to organize countries, product context, source status, evidence gaps, review ownership, and next actions before relying on market-access assumptions.

Professional review remains part of the workflow.